Non-treatment-related chronic myeloid leukemia as a second malignancy

Author： Specchia G.   Buquicchio C.   Albano F.   Liso A.   Pannunzio A.   Mestice A.   Rizzi R.   Pastore D.   Liso V.  

Publisher： Elsevier

ISSN： 0145-2126

Source： Leukemia Research, Vol.28, Iss.2, 2004-02, pp. : 115-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine

By García-Muñoz Ricardo   García Diana   Roldán-Galiacho Verónica   Merchante-Andreu Miriam   Campeny-Najara Andrea   Rabasa Pilar  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 699-702

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib Mesylate in Chronic Myeloid Leukemia

By  

Current Stem Cell Research & Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 249-251

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of altered proteins related to blast crisis in chronic myeloid leukemia by proteomic study

By  

International Journal Of Laboratory Hematology, Vol. 34, Iss. 3, 2012-06 ,pp. : 267-273

John Wiley & Sons Inc

Access to resources Recommend Favorite

Portofino International Conference on Chronic Myeloid Leukemia

By Carella A.M.   Melo J.V.   Goldman J.M.  

Experimental Hematology, Vol. 29, Iss. 10, 2001-10 ,pp. : 1147-1156

Elsevier

Access to resources Recommend Favorite

Bilateral Hypopyon as the Presenting Feature of Chronic Myeloid Leukemia

By Sudharshan Sridharan   Kumari Anjana   Biswas Jyotirmay  

Ocular Immunology and Inflammation, Vol. 16, Iss. 5-6, 2008-09 ,pp. : 244-246

Informa Healthcare

Access to resources Recommend Favorite